Combination beta-adrenergic blockade and immunotherapy for the treatment of primary and metastatic brain cancer.
Publication
, Conference
Lorrey, S; Wachsmuth, LP; Ostrom, QT; Fecci, PE
Published in: JOURNAL OF CLINICAL ONCOLOGY
2023
Duke Scholars
Published In
JOURNAL OF CLINICAL ONCOLOGY
EISSN
1527-7755
ISSN
0732-183X
Publication Date
2023
Volume
41
Issue
16
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 1112 Oncology and Carcinogenesis
- 1103 Clinical Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Lorrey, S., Wachsmuth, L. P., Ostrom, Q. T., & Fecci, P. E. (2023). Combination beta-adrenergic blockade and immunotherapy for the treatment of primary and metastatic brain cancer. In JOURNAL OF CLINICAL ONCOLOGY (Vol. 41).
Lorrey, Selena, Lucas P. Wachsmuth, Quinn T. Ostrom, and Peter E. Fecci. “Combination beta-adrenergic blockade and immunotherapy for the treatment of primary and metastatic brain cancer.” In JOURNAL OF CLINICAL ONCOLOGY, Vol. 41, 2023.
Lorrey S, Wachsmuth LP, Ostrom QT, Fecci PE. Combination beta-adrenergic blockade and immunotherapy for the treatment of primary and metastatic brain cancer. In: JOURNAL OF CLINICAL ONCOLOGY. 2023.
Lorrey, Selena, et al. “Combination beta-adrenergic blockade and immunotherapy for the treatment of primary and metastatic brain cancer.” JOURNAL OF CLINICAL ONCOLOGY, vol. 41, no. 16, 2023.
Lorrey S, Wachsmuth LP, Ostrom QT, Fecci PE. Combination beta-adrenergic blockade and immunotherapy for the treatment of primary and metastatic brain cancer. JOURNAL OF CLINICAL ONCOLOGY. 2023.
Published In
JOURNAL OF CLINICAL ONCOLOGY
EISSN
1527-7755
ISSN
0732-183X
Publication Date
2023
Volume
41
Issue
16
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 1112 Oncology and Carcinogenesis
- 1103 Clinical Sciences